ArticleCureus2023
Long-Term Survival After Repeated Salvage Chemoradiation Therapy for Metastatic Lymph Node Recurrence in Advanced Gastric Cancer: A Case Report.
Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metastatic recurrence in advanced gastric cancer is a poor prognosis, and where recently novel systemic therapies have been investigated. This case report describes the successful use of repeated salvage chemoradiation therapy in a patient with advanced gastric cancer who had failed initial treatments. The patient achieved long-term survival and remained disease-free for several years after treatment. The report highlights the potential benefits of salvage chemoradiation therapy in selected patients with advanced gastric cancer and the need for further studies to determine the optimal treatment approach for these patients. The report also discusses recent promising results from clinical trials of combination regimens with immune checkpoint inhibitors and targeted therapies in the management of advanced gastric cancer. Overall, the report highlights the ongoing challenge of managing advanced gastric cancer and the importance of personalized treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.